Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Environmental neurotoxin-induced progressive model of parkinsonism in rats.

Shen WB, McDowell KA, Siebert AA, Clark SM, Dugger NV, Valentino KM, Jinnah HA, Sztalryd C, Fishman PS, Shaw CA, Jafri MS, Yarowsky PJ.

Ann Neurol. 2010 Jul;68(1):70-80. doi: 10.1002/ana.22018.

2.

Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour.

Wilson JM, Khabazian I, Wong MC, Seyedalikhani A, Bains JS, Pasqualotto BA, Williams DE, Andersen RJ, Simpson RJ, Smith R, Craig UK, Kurland LT, Shaw CA.

Neuromolecular Med. 2002;1(3):207-21.

PMID:
12095162
3.

Sleep alterations in an environmental neurotoxin-induced model of parkinsonism.

McDowell KA, Hadjimarkou MM, Viechweg S, Rose AE, Clark SM, Yarowsky PJ, Mong JA.

Exp Neurol. 2010 Nov;226(1):84-9. doi: 10.1016/j.expneurol.2010.08.005. Epub 2010 Aug 14.

4.

Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy.

Wilson JM, Petrik MS, Grant SC, Blackband SJ, Lai J, Shaw CA.

Neuroimage. 2004 Sep;23(1):336-43.

PMID:
15325381
5.

Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.

Khabazian I, Bains JS, Williams DE, Cheung J, Wilson JM, Pasqualotto BA, Pelech SL, Andersen RJ, Wang YT, Liu L, Nagai A, Kim SU, Craig UK, Shaw CA.

J Neurochem. 2002 Aug;82(3):516-28.

6.

Washed cycad flour contains β-N-methyl amino-L-alanine and may explain parkinsonism symptoms.

Banack SA, Nunn PB, Cheng R, Bradley WG.

Ann Neurol. 2011 Feb;69(2):423; author reply 423-4. doi: 10.1002/ana.22291. No abstract available.

PMID:
21387387
7.

Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.

Wilson JM, Petrik MS, Moghadasian MH, Shaw CA.

Can J Physiol Pharmacol. 2005 Feb;83(2):131-41.

PMID:
15791286
8.

Chronic exposure to dietary sterol glucosides is neurotoxic to motor neurons and induces an ALS-PDC phenotype.

Tabata RC, Wilson JM, Ly P, Zwiegers P, Kwok D, Van Kampen JM, Cashman N, Shaw CA.

Neuromolecular Med. 2008;10(1):24-39. doi: 10.1007/s12017-007-8020-z. Epub 2008 Jan 15.

10.

Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin.

Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC.

Science. 1987 Jul 31;237(4814):517-22.

PMID:
3603037
12.

Late appearance of glutamate transporter defects in a murine model of ALS-parkinsonism dementia complex.

Wilson JM, Shaw CA.

Neurochem Int. 2007 Jun;50(7-8):1067-77. Epub 2006 Nov 13. Review.

PMID:
17095122
13.

Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator.

Schulz JD, Hawkes EL, Shaw CA.

Med Hypotheses. 2006;66(6):1222-6. Epub 2006 Feb 20.

PMID:
16488551
14.
15.

Striatal neuroinflammation promotes Parkinsonism in rats.

Choi DY, Liu M, Hunter RL, Cass WA, Pandya JD, Sullivan PG, Shin EJ, Kim HC, Gash DM, Bing G.

PLoS One. 2009;4(5):e5482. doi: 10.1371/journal.pone.0005482. Epub 2009 May 8.

16.
17.

The primary locus of motor neuron death in an ALS-PDC mouse model.

Lee G, Chu T, Shaw CA.

Neuroreport. 2009 Sep 23;20(14):1284-9. doi: 10.1097/WNR.0b013e32833037ae.

18.

Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models.

Shaw CA, Wilson JM.

Neurosci Biobehav Rev. 2003 Oct;27(6):493-505. Review.

PMID:
14599431
19.

Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats.

Banerjee R, Sreetama S, Saravanan KS, Chandra G, Nath De S, Mohanakumar KP.

J Chem Neuroanat. 2006 Dec;32(2-4):90-100. Epub 2006 Jul 5.

PMID:
16822645
20.

Supplemental Content

Support Center